These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24960041)

  • 1. A novel nodal enhancer dependent on pluripotency factors and smad2/3 signaling conditions a regulatory switch during epiblast maturation.
    Papanayotou C; Benhaddou A; Camus A; Perea-Gomez A; Jouneau A; Mezger V; Langa F; Ott S; Sabéran-Djoneidi D; Collignon J
    PLoS Biol; 2014 Jun; 12(6):e1001890. PubMed ID: 24960041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.
    Sun LT; Yamaguchi S; Hirano K; Ichisaka T; Kuroda T; Tada T
    Dev Biol; 2014 Aug; 392(2):182-92. PubMed ID: 24929238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.
    Sakaki-Yumoto M; Liu J; Ramalho-Santos M; Yoshida N; Derynck R
    J Biol Chem; 2013 Jun; 288(25):18546-60. PubMed ID: 23649632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.
    Vallier L; Mendjan S; Brown S; Chng Z; Teo A; Smithers LE; Trotter MW; Cho CH; Martinez A; Rugg-Gunn P; Brons G; Pedersen RA
    Development; 2009 Apr; 136(8):1339-49. PubMed ID: 19279133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graded Nodal/Activin signaling titrates conversion of quantitative phospho-Smad2 levels into qualitative embryonic stem cell fate decisions.
    Lee KL; Lim SK; Orlov YL; Yit le Y; Yang H; Ang LT; Poellinger L; Lim B
    PLoS Genet; 2011 Jun; 7(6):e1002130. PubMed ID: 21731500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal cis-regulatory elements reveal epiblast and primitive endoderm heterogeneity in the peri-implantation mouse embryo.
    Granier C; Gurchenkov V; Perea-Gomez A; Camus A; Ott S; Papanayotou C; Iranzo J; Moreau A; Reid J; Koentges G; Sabéran-Djoneidi D; Collignon J
    Dev Biol; 2011 Jan; 349(2):350-62. PubMed ID: 21047506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response of epiblast stem cells to Nodal and Activin signalling: a paradigm of early endoderm development in the embryo.
    Kaufman-Francis K; Goh HN; Kojima Y; Studdert JB; Jones V; Power MD; Wilkie E; Teber E; Loebel DA; Tam PP
    Philos Trans R Soc Lond B Biol Sci; 2014 Dec; 369(1657):. PubMed ID: 25349457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.
    Chng Z; Teo A; Pedersen RA; Vallier L
    Cell Stem Cell; 2010 Jan; 6(1):59-70. PubMed ID: 20074535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors.
    Brown S; Teo A; Pauklin S; Hannan N; Cho CH; Lim B; Vardy L; Dunn NR; Trotter M; Pedersen R; Vallier L
    Stem Cells; 2011 Aug; 29(8):1176-85. PubMed ID: 21630377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel investigation of NANOG and POU5F1 associations in the pluripotent characterization of ES-like and epiblast cells.
    Roshan MM; Azizi H; Sojoudi K
    Sci Rep; 2024 Oct; 14(1):24092. PubMed ID: 39406879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial Smad2/3 Activities Downstream of Nodal Signaling Maintain Embryonic/Extra-Embryonic Cell Identities during Lineage Priming.
    Senft AD; Costello I; King HW; Mould AW; Bikoff EK; Robertson EJ
    Cell Rep; 2018 Aug; 24(8):1977-1985.e7. PubMed ID: 30134160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of ground-state pluripotency by allelic regulation of Nanog.
    Miyanari Y; Torres-Padilla ME
    Nature; 2012 Feb; 483(7390):470-3. PubMed ID: 22327294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the Otx2-Binding Site in the Nanog Promoter Affects the Integrity of Embryonic Stem Cell Subtypes and Specification of Inner Cell Mass-Derived Epiblast.
    Acampora D; Omodei D; Petrosino G; Garofalo A; Savarese M; Nigro V; Di Giovannantonio LG; Mercadante V; Simeone A
    Cell Rep; 2016 Jun; 15(12):2651-64. PubMed ID: 27292645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epiblast stem cells contribute new insight into pluripotency and gastrulation.
    Chenoweth JG; McKay RD; Tesar PJ
    Dev Growth Differ; 2010 Apr; 52(3):293-301. PubMed ID: 20298258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iTRAQ proteome analysis reflects a progressed differentiation state of epiblast derived versus inner cell mass derived murine embryonic stem cells.
    Fröhlich T; Kösters M; Graf A; Wolf E; Kobolak J; Brochard V; Dinnyés A; Jouneau A; Arnold GJ
    J Proteomics; 2013 Sep; 90():38-51. PubMed ID: 23603003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient derivation of bovine embryonic stem cells needs more than active core pluripotency factors.
    Maruotti J; Muñoz M; Degrelle SA; Gómez E; Louet C; Díez C; de Longchamp PH; Brochard V; Hue I; Caamaño JN; Jouneau A
    Mol Reprod Dev; 2012 Jul; 79(7):461-77. PubMed ID: 22573702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein.
    Turco MY; Furia L; Dietze A; Fernandez Diaz L; Ronzoni S; Sciullo A; Simeone A; Constam D; Faretta M; Lanfrancone L
    Stem Cells; 2012 Nov; 30(11):2423-36. PubMed ID: 22948967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of genomic imprinting in epigenetically distinct pluripotent stem cells.
    Sun B; Ito M; Mendjan S; Ito Y; Brons IG; Murrell A; Vallier L; Ferguson-Smith AC; Pedersen RA
    Stem Cells; 2012 Feb; 30(2):161-8. PubMed ID: 22109880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.
    Beyer TA; Weiss A; Khomchuk Y; Huang K; Ogunjimi AA; Varelas X; Wrana JL
    Cell Rep; 2013 Dec; 5(6):1611-24. PubMed ID: 24332857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells.
    Gaspar JA; Doss MX; Winkler J; Wagh V; Hescheler J; Kolde R; Vilo J; Schulz H; Sachinidis A
    Stem Cells Dev; 2012 Sep; 21(13):2471-84. PubMed ID: 22420508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.